TriMark Publications, May 2008, Pages: 182
... Drugs Used in Bladder Cancer Therapy 69 Table 5.2: Drugs in Development for Bladder Cancer 71 Table 5.3: Medicines in Development for Brain Cancer 72 Table 5.4 ...
Datamonitor, July 2005, Pages: 144
... availability 50 Temozolomide, European Medicines Agency application ... to hamper drug development 53 Adverse ... Despite low incidence brain cancer exerts significant ...
Business Insights, Nov 2002, Pages: 252
...development for bladder cancer 112Table 4.19: Brain cancer patient statistics ... sales, 2002?05 144Table 4.26: Selected medicines in development for cervical ...
Frost & Sullivan, Aug 2007, Pages: 124
... due to increasing awareness ---e. Higher incidence of head and neck ... to other diseases limits R&D expenditure ---c. Fewer medicines in development for cancer...
Jain PharmaBiotech, Nov 2009, Pages: 681
... therapy of medulloblastomas Personalized management of germ cell brain tumors Future of ...Development of Personalized Medicine Introduction Non ...
Spectra Intelligence, Nov 2006, Pages: 367
... Table 8.3 Major Preclinical Developments in Brain Cancer Therapeutics Table ... detail, particularly as they relate to the development of new cancer medicines. ...
Datamonitor, Oct 2009, Pages: 51
... Personalized management of germ cell brain tumors Future ... in developing personalized cancer therapy 10 Development of Personalized Medicine Introduction Non ...
Bizacumen Inc., Nov 2009, Pages: 252
... standard cytotoxic therapies towards MTTs and personalized medicine. ... the current CRC pipeline by developmental phase, drug ... Phase II head-to-head trial against ...
TriMark Publications, April 2008, Pages: 274
... Advancements in nuclear medicine technology would represent a ... 42 5. RESEARCH & DEVELOPMENT BREAKTHROUGHS 44 ... Potential of Cotara® for Brain Cancer Treatment 44 ...
Frost & Sullivan, Sep 2005 ... 236 10.2 Telomerase 239 10.3 Stomach Cancer 241 10.4 Head and Neck ... 2005-2008 INDEX OF TABLES Table 2.1: Organ-Specific Medicines in Development for Cancer...
Frost & Sullivan, March 2004 ... and Communication Technology - - - b. Developments in Storage ... SPECT/CT in the Nuclear Medicine - - 4. Combined ... 1. Incidence of Brain Cancer - - 2. Incidence of ...
Greystone Associates, July 2008 ... as neuropsychiatry, cardiovascular medicine, endocrinology, and ... Early-Phase Drug Development Using Nanotechnology ... Therapeutics Finds Brain Cancer Target Ariad ...
New MEdicine Inc. ... Standardization and Personalized Medicine Branded Therapeutic ... CDX-110 - QbG10 Development-stage Vaccine ... & Commercial Assessment - Brain Cancer - Breast Cancer...
Jain PharmaBiotech, Nov 2009, Pages: 768
... 5: Role of biomarkers in translational medicine Table 2 ... Table 4-3: Biomarker-based drug development at major ...cancer Table 6-5: Biomarkers of brain tumors Table 6 ...
Research Facts Ltd, April 2009, Pages: 107
... Drugs in Development, Markets and Developers ... Society of Nuclear Medicine; International Congress ... Prostate Cancer -Ovarian Cancer -Brain Cancer -Breast Cancer...
Datamonitor, April 2005, Pages: 203
... 6: Role of biomarkers in translational medicine Table 2 ... Table 4-3: Biomarker-based drug development at major ...cancer Table 6-4: Biomarkers of brain tumors Table 6 ...
Jain PharmaBiotech, Nov 2009, Pages: 451
... services including: product development, formulation and ... Ovarian Cancer, Skin Cancer, Brain Cancer, Bone Metastasis. ... in physiology and medicine from Trinity ...
Frost & Sullivan, March 2007 ... vaccines in late-stage development Pipeline overview ... Cerundolo, Professor of Immunology, Head Cancer Research UK ... Institute of Molecular Medicine, University of ...
John Wiley and Sons Ltd, Nov 2007, Pages: 264
... various cancer types RNAi-based therapy of brain cancer RNAi in ... Role of RNAi in development of personalized medicine Challenges for the development of RNAi ...
Decision Resources, Inc., Sep 2008, Pages: 37
... 236 10.2 Telomerase 239 10.3 Stomach Cancer 241 10.4 Head and Neck ... 2005-2008 INDEX OF TABLES Table 2.1: Organ-Specific Medicines in Development for Cancer...
